-
Your Portfolio's Diet Should Include A Serving Of NutriSystem After Strong Results In Q4
Tuesday, February 28, 2017 - 9:18am | 383Read More...NutriSystem Inc. (NASDAQ: NTRI) report strong fourth-quarter 2016 results, beating the estimates on each metric, while issuing its 2017 guidance ahead of expectations, primarily due to mid-teens growth in the core NutriSystem brand. Wunderlich’s Mitchell B. Pinheiro maintains a Buy rating on...
-
Flowers Foods' Growth Story Intact Despite Legal Woes
Friday, January 13, 2017 - 11:48am | 350Read More...Although Flowers Foods, Inc. (NYSE: FLO) may report lackluster results for Q4 2016, its performance will likely improve in the first quarter of 2017 against easier comps, Wunderlich’s Mitchell B. Pinheiro said in a report. He added that the company could exceed the current investor...
-
SunOpta's Forecast Looking Brighter
Tuesday, October 11, 2016 - 11:55am | 320Read More...SunOpta, Inc. (USA) (NASDAQ: STKL) has significantly underperformed over the past several years, and now seems to be “in the early stages of a recovery,” Wunderlich’s Mitchell B. Pinheiro said in a report. He initiated coverage of the company with a Buy rating and $10 price...
-
Wunderlich On Inventure Foods: 'On Track, But Leverage Concerns Permeate'
Monday, May 23, 2016 - 10:17am | 270Read More...Wunderlich’s Mitchell B. Pinheiro expects Inventure Foods Inc (NASDAQ: SNAK) to witness sequential margin and revenue improvement through 2016, along with overall margins achieving a more normalized run rate in 4Q16. Pinheiro maintains a Buy rating on the company, with a price target of $10....
-
Imperial Capital Reiterates Outperform, Raises PT On Landec On 3Q15 Update
Thursday, April 2, 2015 - 7:43am | 198Read More...In a report published Thursday, Imperial Capital analyst Mitchell B. Pinheiro reiterated an Outperform rating on Landec Corporation (NASDAQ: LNDC), and raised the price target from $17.00 to $18.00. In the report, Imperial Capital noted, "We are maintaining our Outperform rating on LNDC shares and...
-
UPDATE: Imperial Capital Upgrades Lifeway Foods On 4Q14 Results
Wednesday, March 18, 2015 - 9:27am | 225Read More...In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro upgraded the rating on Lifeway Foods, Inc. (NASDAQ: LWAY) from In-Line to Outperform, and raised the price target from $17.00 to $22.00. In the report, Imperial Capital noted, "Our price target is about 22% above LWAY's...
-
Imperial Capital Reiterates Outperform, Lowers PT On SunOpta On 4Q14 Earnings Update
Wednesday, March 11, 2015 - 9:08am | 234Read More...In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro reiterated an Outperform rating on SunOpta, Inc. (USA) (NASDAQ: STKL), but lowered the price target from $16.00 to $15.00. In the report, Imperial Capital noted, "We are maintaining our Outperform rating and lowering our...
-
Imperial Capital Reiterates Outperform, Raises Price Target On WhiteWave Foods On 4Q14 Earnings Update
Wednesday, February 25, 2015 - 11:23am | 258Read More...In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro reiterated an Outperform rating on WhiteWave Foods Co. (NYSE: WWAV), and raised the price target from $40.00 to $46.00. In the report, Imperial Capital noted, "We are maintaining our Outperform rating on shares of The...
-
UPDATE: Imperial Capital Initiates Coverage on Nutraceutical International as Attractive Pure-Play
Wednesday, February 26, 2014 - 8:48am | 121Read More...In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on Nutraceutical International Corporation (NASDAQ: NUTR) with an Outperform rating and $32.00 price target. In the report, Imperial Capital noted, “We are initiating coverage of Nutraceutical...
-
UPDATE: Imperial Capital Initiates Coverage on LifeVantage Awaiting Renewed Distributor Growth
Wednesday, February 12, 2014 - 9:00am | 195Read More...In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on LifeVantage (NASDAQ: LFVN) with an In-Line rating and $2.10 price target. In the report, Imperial Capital noted, “We are initiating coverage of LifeVantage Corporation (LFVN) with an In-Line rating...
-
UPDATE: Imperial Capital Downgrades Omega Protein on Valuation
Tuesday, November 26, 2013 - 9:10am | 193Read More...In a report published Tuesday, Imperial Capital analyst Mitchell B. Pinheiro downgraded the rating on Omega Protein Corporation (NYSE: OME) from Outperform to In-Line, but reiterated the $15.00 price target. In the report, Imperial Capital noted, “We are lowering our rates on the shares of Omega...
-
UPDATE: Imperial Capital Initiates Coverage on Vitacost.com on Favorable Entry Point
Wednesday, November 20, 2013 - 9:21am | 137Read More...In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on Vitacost.com (NASDAQ: VITC) with an Outperform rating and $8.00 price target. In the report, Imperial Capital noted, “We are initiating coverage of Vitacost.com, Inc. (VITC) with an Outperform...
-
UPDATE: Imperial Capital Initiates Coverage on Lifeway Foods as Valuation is Tough to Digest
Wednesday, October 23, 2013 - 8:35am | 128Read More...In a report published Wednesday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on Lifeway Foods (NASDAQ: LWAY) with an In-Line rating and $16.00 price target. In the report, Imperial Capital noted, “We are initiating coverage on Lifeway Foods (LWAY) with an In-Line rating and...
-
UPDATE: Imperial Capital Initiates Coverage on SunOpta on Great Upside Potential
Thursday, October 10, 2013 - 11:19am | 127Read More...In a report published Thursday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on SunOpta (NASDAQ: STKL) with an Outperform rating and $13.00 price target. In the report, Imperial Capital noted, “We are initiating coverage of SunOpta, Inc. (STKL) with an Outperform rating and one...
-
UPDATE: Imperial Capital Initiates Coverage on Medifast on Attractive Entry Point
Friday, September 6, 2013 - 10:26am | 131Read More...In a report published Friday, Imperial Capital analyst Mitchell B. Pinheiro initiated coverage on Medifast (NYSE: MED) with an Outperform rating and $30.00 price target. In the report, Imperial Capital noted, “We are initiating coverage of Medifast, Inc. (MED) with an Outperform rating and a one-...
